Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma

Description

This clinical trial aims to evaluate whether a psychosocial mobile application (THRIVE-M), is efficacious for improving quality of life, psychological distress, and fatigue in patients living with multiple myeloma compared to usual care.

Conditions

Multiple Myeloma

Talk to us

Study Overview

On this page

Study Details

Study overview

This clinical trial aims to evaluate whether a psychosocial mobile application (THRIVE-M), is efficacious for improving quality of life, psychological distress, and fatigue in patients living with multiple myeloma compared to usual care.

Randomized Controlled Trial of a Psychosocial Mobile Application (THRIVE-M) for Patients Living With Multiple Myeloma

Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma

Condition
Multiple Myeloma
Intervention / Treatment

-

Contacts and Locations

Boston

Massachusetts General Hospital, Boston, Massachusetts, United States, 02115

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients (aged 18 years or older) with one of the following diagnoses:
  • 1. newly diagnosed multiple myeloma receiving first-line therapy,
  • 2. multiple myeloma on maintenance therapy, or
  • 3. relapsed multiple myeloma receiving 2nd or 3rd line therapy
  • * Ability to comprehend, read, and respond to questions in English

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

Areej El-Jawahri, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2025-03-31